Zynerba Pharmaceuticals zynerba.com


Public list: Cannabis (1939) Pharma Startups (6570) Rare Diseases (230)

Zynerba Pharmaceuticals is a clinical-stage pharmaceutical company that is dedicated to the development of innovative transdermal synthetic cannabinoid treatments for patients with high unmet medical needs.

Zynerba Pharmaceuticals is a clinical-stage pharmaceutical company that is dedicated to the development of innovative transdermal synthetic cannabinoid treatments for patients with high unmet medical needs.

Company (IPO / Went public)

Phone: 484-581-7505

Fax:

80 W Lancaster Avenue
Suite 300
Devon, 19333
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Zynerba Pharmaceuticals $13M Aug 5, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Zynerba Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Treatment of fragile x syndrome with cannabidiol Oct 07, 2019 Sep 01, 2020 Patent
Use of cannabidiol prodrugs in pharmaceutical compositions Dec 13, 2018 Mar 03, 2020 Patent
Treatment of autism with cannabidiol May 14, 2019 Feb 25, 2020 Patent
Treatment of fragile x syndrome with cannabidiol Jan 16, 2019 Nov 12, 2019 Patent
Treatment of autism with cannabidiol Dec 14, 2018 Jun 11, 2019 Patent
See all 22 patents